术前曲马多管理疼痛:全髋关节置换术前传统阿片类药物的安全替代?
该研究基于Humana理赔数据库2008至2014年因退行性髋病行初次全髋关节置换术的5304例患者,按术前疼痛管理方式分为曲马多、传统阿片类和非阿片类三组。多因素逻辑回归显示,曲马多组较非阿片组 prolonged narcotic use 风险升高,但较传统阿片组在90天轻微医疗并发症、急诊就诊和 prolonged narcotic use 风险上降低,且传统阿片组住院时间较曲马多组延长0.20天。
要点
- 术前曲马多组较非阿片组 prolonged narcotic use 风险升高(OR 2.17)。
- 曲马多组较传统阿片组90天轻微并发症、急诊就诊和 prolonged narcotic use 风险更低。
- 传统阿片组住院时间较曲马多组延长0.20天。
核心结论
- 术前曲马多使用与全髋关节置换术后 prolonged opioid use 相关,但与其他术后并发症无关。
- 术前使用曲马多的患者较术前使用传统阿片类药物的患者术后并发症风险更低。
研究设计与样本
- 回顾性队列研究,使用Humana理赔数据库识别2008至2014年因退行性髋病行初次全髋关节置换术的5304例患者。
- 患者按术前疼痛管理方式分为曲马多、传统阿片类和非阿片类三组,采用多因素逻辑回归评估术后结局。
主要发现
- 传统阿片组较曲马多组住院时间延长0.20天(P = .001)。
临床怎么用
- 全髋关节置换术前使用曲马多管理疼痛的患者,术后 prolonged opioid use 风险仍高于非阿片类使用者。
- 与传统阿片类药物相比,术前曲马多可能降低术后90天轻微并发症、急诊就诊和 prolonged opioid use 风险,并缩短住院时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative opioid use has been associated with worse clinical outcomes and higher rates of prolonged opioid use following lower extremity arthroplasty. Tramadol has been recommended for management of osteoarthritis-related pain; however, outcomes following total hip arthroplasty (THA) in patients taking tramadol in the preoperative period have not been well described. The aim of this study is to examine the effect of preoperative tramadol use on postoperative outcomes in patients undergoing elective THA. METHODS: A total of 5304 patients who underwent primary THA for degenerative hip pathology from 2008 to 2014 were identified using the Humana Claims Database. Patients were grouped by preoperative pain management modality into 3 mutually exclusive populations including tramadol, traditional opioid, or nonopioid only. A multivariate logistic regression was used to evaluate all postsurgical outcomes of interest. RESULTS: Tramadol users had an increased risk of developing prolonged narcotic use (odds ratio [OR], 2.17; confidence interval [CI], 1.89-2.49; P < .001) following surgery compared to nonopioid-only users. When compared to traditional opioid use, tramadol use was associated with decreased risk of subsequent 90-day minor medical complications (OR, 0.75; CI, 0.62-0.90; P = .002), emergency department visits (OR, 0.70; CI, 0.57-0.85; P < .001), and prolonged narcotic use (OR, 0.43; CI, 0.37-0.49; P < .001). Traditional opioid use significantly increased length of stay by 0.20 days (P = .001) when compared to tramadol use. CONCLUSION: Preoperative tramadol use is associated with prolonged opioid use following THA but is not associated with other postoperative complications. Patients taking tramadol preoperatively appear to have a lower risk of postoperative complications compared to patients taking traditional opioids preoperatively.
引用
- Bell JE, Sequeira SB, Chen DQ, et al. Preoperative Pain Management: Is Tramadol a Safe Alternative to Traditional Opioids Before Total Hip Arthroplasty? J Arthroplasty. 2020. PMID: 32466997. doi:10.1016/j.arth.2020.04.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。